Effects of Exenatide on Measures of Diabetic Neuropathy in Subjects with Type 2 Diabetes: Results from an 18-Month Proof-of-Concept Open Label Randomized Study

OBJECTIVE: Experimental studies have reported potential benefit of glucagon-like peptide-1(GLP-1) receptor agonists in preventing diabetic peripheral neuropathy (DPN). We therefore performed a proof-of-concept pilot study to evaluate the effect of exenatide, a GLP-1 agonist, on measures of DPN and c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Diabetes Complications
Main Authors: Jaiswal, Mamta, Martin, Catherine L, Brown, Morton B., Callaghan, Brian, Albers, James W., Feldman, Eva L., Pop-Busui, Rodica
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4656068/
https://ncbi.nlm.nih.gov/pubmed/26264399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdiacomp.2015.07.013
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki